CN109699744A - A kind of auxiliary hyperglycemic milk powder and preparation method thereof - Google Patents
A kind of auxiliary hyperglycemic milk powder and preparation method thereof Download PDFInfo
- Publication number
- CN109699744A CN109699744A CN201811611351.0A CN201811611351A CN109699744A CN 109699744 A CN109699744 A CN 109699744A CN 201811611351 A CN201811611351 A CN 201811611351A CN 109699744 A CN109699744 A CN 109699744A
- Authority
- CN
- China
- Prior art keywords
- milk
- vitamin
- milk powder
- auxiliary hyperglycemic
- wet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 80
- 235000013336 milk Nutrition 0.000 title claims abstract description 76
- 239000008267 milk Substances 0.000 title claims abstract description 76
- 210000004080 milk Anatomy 0.000 title claims abstract description 76
- 230000003345 hyperglycaemic effect Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 6
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract description 66
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 38
- 239000011707 mineral Substances 0.000 claims abstract description 38
- 239000002994 raw material Substances 0.000 claims abstract description 36
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 33
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 33
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 31
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 31
- 235000021239 milk protein Nutrition 0.000 claims abstract description 31
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229920001353 Dextrin Polymers 0.000 claims abstract description 22
- 239000004375 Dextrin Substances 0.000 claims abstract description 22
- 235000019425 dextrin Nutrition 0.000 claims abstract description 22
- 229920001202 Inulin Polymers 0.000 claims abstract description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 20
- 229940029339 inulin Drugs 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 20
- 235000020247 cow milk Nutrition 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 8
- 229930195729 fatty acid Natural products 0.000 claims abstract description 8
- 239000000194 fatty acid Substances 0.000 claims abstract description 8
- 239000002131 composite material Substances 0.000 claims description 34
- 229940088594 vitamin Drugs 0.000 claims description 34
- 239000011782 vitamin Substances 0.000 claims description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 26
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 24
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 22
- 108010046377 Whey Proteins Proteins 0.000 claims description 19
- 230000008859 change Effects 0.000 claims description 19
- 102000007544 Whey Proteins Human genes 0.000 claims description 18
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 14
- 229930003268 Vitamin C Natural products 0.000 claims description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 14
- 235000019155 vitamin A Nutrition 0.000 claims description 14
- 239000011719 vitamin A Substances 0.000 claims description 14
- 235000019154 vitamin C Nutrition 0.000 claims description 14
- 239000011718 vitamin C Substances 0.000 claims description 14
- 229940045997 vitamin a Drugs 0.000 claims description 14
- 229930003427 Vitamin E Natural products 0.000 claims description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- 235000019165 vitamin E Nutrition 0.000 claims description 13
- 239000011709 vitamin E Substances 0.000 claims description 13
- 229940046009 vitamin E Drugs 0.000 claims description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 12
- 229910052791 calcium Inorganic materials 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 12
- 239000011726 vitamin B6 Substances 0.000 claims description 12
- 239000011701 zinc Substances 0.000 claims description 12
- 229910052725 zinc Inorganic materials 0.000 claims description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 11
- 229930003316 Vitamin D Natural products 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- 229960000304 folic acid Drugs 0.000 claims description 11
- 239000011724 folic acid Substances 0.000 claims description 11
- 235000019152 folic acid Nutrition 0.000 claims description 11
- 238000000265 homogenisation Methods 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 11
- 239000011710 vitamin D Substances 0.000 claims description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 11
- 229940046008 vitamin d Drugs 0.000 claims description 11
- 235000021119 whey protein Nutrition 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000001694 spray drying Methods 0.000 claims description 9
- 239000005862 Whey Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 125000005313 fatty acid group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 230000004630 mental health Effects 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- 235000020183 skimmed milk Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 235000020185 raw untreated milk Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- -1 Ru Yuan Albumen Chemical compound 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000010237 hybrid technique Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A kind of auxiliary hyperglycemic milk powder disclosed by the invention, raw material include cow's milk, resistant dextrin, medium chain triglyceride, inulin, milk protein.The present invention also provides the methods for preparing the milk powder, can prepare the milk powder using wet process and/or dry and wet mixing method.The function of blood sugar reduction perfect combination of the control blood glucose and alpha-lipoic acid of resistant dextrin is strengthened several mineral materials by advantage of the present invention, the milk powder of auxiliary hyperglycemic of the invention, multivitamin, optimization fatty acid composition etc..Milk powder of the invention not only can effectively improve the blood glucose level of diabetic, but also full nutrition can be provided for diabetic, had not only been beneficial to the health of diabetic but also had been beneficial to its physical and mental health.
Description
Technical field
The invention belongs to technical field of processing dairy products, specially a kind of auxiliary hyperglycemic milk powder and preparation method thereof.
Background technique
Diabetes are one group of metabolic diseases characterized by hyperglycemia.The characteristic symptom of the disease is diuresis (urine life
At excessive), more drinks, weight loss.Long-standing hyperglycemia when diabetes also results in eye, kidney, heart, blood vessel, nerve
Chronic lesion, dysfunction.There are about 100,000,000 diabetics in China, and occupy first of various countries；Annual China is several because diabetes will be spent
Hundred billion medical expense.People once suffers from diabetes and is difficult to eradicate, but can reduce antidiabetic drug by dietary adjustments
The use of object is realized even for part patients with mild and is also able to achieve effective control blood glucose level without using hypoglycemic medicine.
And with the fast development of food industrialization, purified diet on the market is more and more, along with human lives'
Rhythm is getting faster, buy ready-made industrialization product carry out consumption account for ratio is also higher and higher, this results in the mankind to obtain
The chance of natural food is fewer and fewer, and the chance for obtaining natural nutrient possessed by food is fewer and fewer.Especially refine
Afterwards, the mankind obtain healthy and beneficial to human body intestinal canal in food, and the amount of the beneficial dietary fiber of glycemic control is fewer and fewer, obtain day
The amount of right antioxidant alpha-lipoic acid is fewer and fewer.Alpha-lipoic acid can be such that the responsibility of insulin restores, and patient is helped to reduce
Dependence to insulin and hypoglycemic medicine, the ability of enhancing body synthesis hepatic glycogen, makes glycometabolism restore normal, to reduce blood
Sugar value；In addition, alpha-lipoic acid also has the function of prevention or treatment Peripheral neuropathy, help to be particularly suitable for diabetic's clothes
With.
Summary of the invention
To solve the problem of that food is mostly to finish the ingredient containing helpful glycometabolism to tail off in the prior art, the present invention
A kind of auxiliary hyperglycemic milk powder and preparation method thereof is provided, the purpose of realization is to aim to solve the problem that common dairy products do not have drop blood
The problem of sugar, full of nutrition, the dairy product rich in dietary fiber and alpha-lipoic acid is provided for people.
To achieve the goals above, a kind of milk powder of auxiliary hyperglycemic provided by the invention, raw material include cow's milk
0.00%-96.53%, resistant dextrin 1.43%-12.90%, medium chain triglyceride 0.00%-0.91%, inulin 0.00%-
8.10%, milk protein 0.00%-76.50%, the percentage are the mass percent that each component quality accounts for raw material.
Further, raw material further include alpha-lipoic acid 0.0148%-0.5000%, composite mineral matter 0.1843-
1.6000% and multi-vitamins 0.0231-0.2%, the percentage are the quality percentage that each component quality accounts for raw material
Than.
Milk powder is a kind of full of nutrition and can strengthen or weaken other battalion according to the nutritional need directional trend of each year crowd
Support the product of element.Milk powder of the invention can be with the dietary fiber that is beneficial to diabetes patient's health, the perfections such as minerals, vitamin
Combination, provide the food of nutrient health for diabetes patient, actively correct the metabolic disorder of diabetes patient and reduce it is cardiovascular simultaneously
Send out disease.The milk powder of auxiliary hyperglycemic of the invention is by cow's milk, resistant dextrin, alpha-lipoic acid, milk protein, medium chain triglyceride three
A modulation milk powder of the combinations such as ester, inulin exploitation is additionally beneficial to human body while the milk powder helps to reduce blood glucose
It is physically and mentally healthy.
Wherein, the cow's milk is art technology term, can be divided into raw milk and skimmed milk according to fat content.
In the present invention, the cow's milk can be replaced using whole-fat milk powder and/or skimmed milk powder, wherein the raw milk can be with
It is substituted with whole milk powder commonly used in the art, the skimmed milk can be replaced with skimmed milk commonly used in the art
The conversion ratio of generation, cow's milk and milk powder is converted according to this field conventional ratio, generally are as follows: raw milk quality=rich milk silty
Measure * 0.97/0.117, skimmed milk quality=skimmed milk powder quality * 0.96/0.081.
Wherein, the medium chain triglyceride is medium chain triglyceride commonly used in the art, generally medium chain triglyceride
In three esters and/or medium chain triglyceride fatty powder, preferably fatty acid composition octanoic acid 50%-75%, certain herbaceous plants with big flowers acid 25%-45%
Chain triglyceride.The percentage is the mass percent that each component quality accounts for fatty acid.
Wherein, the alpha-lipoic acid is the alpha-lipoic acid of this field routine.
Wherein, the milk protein is the milk protein of this field routine, refers mainly to whey protein concentrate, milk concentration
Albumen, milk protein isolate, whey protein isolate, desalted whey powder etc., preferably WPC34, MPC60, desalted whey powder D70
With one of D90 or a variety of.
Wherein, the inulin is inulin commonly used in the art.
Wherein, the composite mineral matter is composite mineral matter commonly used in the art.The composite mineral matter is
One of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium or multiple compounds can be provided；The composite mineral matter is preferably every gram again
It closes minerals to contain: calcium: 200-450mg；Iron: 4.0-10mg；Zinc: 2.0-4.5mg；Magnesium: 18-65mg.
Wherein, the multi-vitamins are multi-vitamins commonly used in the art.The multi-vitamins can
To be selected from vitamin A, vitamin D, vitamin E, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, cigarette
One of acid, folic acid, pantothenic acid etc. are a variety of.Preferably every gram of multi-vitamins contain: vitamin A: 6000-14500IU；Dimension
Raw element D:1300-2460IU；Vitamin E: 100-200mg；Vitamin C: 150-500mg；Vitamin B6: 4270-6500 μ g；Leaf
Acid: 1100-2400 μ g.
Wherein, the water is the surplus of the composition of raw materials of the middle auxiliary hyperglycemic milk powder, and the dosage of the water is
This field conventional amount used is generally added and each component phase homogenous quantities that need to be dissolved with meeting it when preparing the milk powder
Water.
The invention also discloses the methods for preparing said milk powder, prepare the milk powder using wet process and/or dry and wet mixing method.
The step of wet process and/or dry and wet mixing method prepare the milk powder include:
(1) raw material are mixed with water, obtains feed liquid A；
(2) feed liquid A is mixed with multi-vitamins, alpha-lipoic acid, composite mineral matter, and through homogeneous, sterilized, spray drying
Obtain material B；
(3) material B is sieved, packaging is got product.
The step of wet process prepares milk powder include:
(21) cow's milk or water are preheated to 45-55 DEG C, then by the resistant dextrin, medium chain triglyceride, Ru Yuan
Albumen, inulin, cow's milk and water are uniformly mixed, and mixing temperature is 45-55 DEG C, obtain mixed liquor A；
(22) multi-vitamins, alpha-lipoic acid, composite mineral matter and the mixed liquor A are uniformly mixed, are carried out equal
Matter is sterilized, and spray drying obtains material B；
(23) it is sieved, packs to the material B to obtain the final product.
The step of preparing milk powder, is combined using wet process and dry method:
(31) cow's milk, resistant dextrin, milk protein, medium chain triglyceride, inulin and water are uniformly mixed, mixing temperature is
45-55 DEG C, obtain mixed liquor A；
(32) homogeneous is carried out to the mixed liquor A, sterilized, material B is made in spray drying；
(33) the material B, multi-vitamins, composite mineral matter and alpha-lipoic acid are uniformly mixed, are sieved, packaging is
?.
Further, the step (2), the water in the step (21) are deionized water, and temperature is 45-55 DEG C.
Further, the step (2), medium chain triglyceride is first preheated to 45-55 DEG C in the step (21), then with
Other ingredient mixing in raw material.
Further, the step (2), first resistant dextrin is mixed with inulin 2:1 in mass ratio in the step (21)
Uniformly, then with other compositions in raw material it mixes.
Further, homogeneous is two in the wet bench step (2), in the wet-dry change binding operation step (22)
Grade homogeneous, wherein the pressure of level-one homogeneous is 15-25MPa, and double-stage homogenization pressure is 1.5-2.5MPa, and the homogenizing temperature is
55-65℃。
Further, the temperature sterilized in the wet bench step (2), in the wet-dry change binding operation step (22)
It is 85-90 DEG C, sterilizing time is 30-45 seconds.
Further, it is spray-dried in the wet bench step (2), in the wet-dry change binding operation step (22)
Inlet air temperature is 165-185 DEG C, and temperature of outgoing air is 80-95 DEG C.
By adopting the above technical scheme, beneficial effect includes: that the milk powder of auxiliary hyperglycemic of the invention pastes resistance to the present invention
The function of blood sugar reduction perfect combination of the control blood glucose and alpha-lipoic acid of essence, and strengthen several mineral materials, multivitamin, optimization fat
Acid composition etc..Milk powder of the invention not only can effectively improve the blood glucose level of diabetic, but also can provide for diabetic entirely
Flour nutrition had not only been beneficial to the health of diabetic but also had been beneficial to its physical and mental health.
Specific embodiment
The present invention is further illustrated below by the mode of embodiment, but does not therefore limit the present invention to the reality
It applies among a range.In the following examples, the experimental methods for specific conditions are not specified, according to conventional methods and conditions, or according to quotient
The selection of product specification.Raw material or reagent used is all commercially available.
Embodiment one: a kind of auxiliary hyperglycemic milk powder of the present invention, raw material include cow's milk 95.52%, resistant dextrin
1.43%, medium chain triglyceride 0.56%, milk protein 1.40%, inulin 0.72%, surplus is water, and the percentage is each
Constituent mass accounts for the mass percent of raw material.
Further, raw material further include alpha-lipoic acid 0.0557%, composite mineral matter 0.2547% and multi-vitamins
0.0319%, the percentage is the mass percent that each component quality accounts for raw material.
Further, the cow's milk is raw milk；
Further, the medium chain triglyceride is in fatty acid composition octanoic acid 50%-75%, certain herbaceous plants with big flowers acid 25%-45%
Chain triglyceride, the percentage are the mass percent that each component quality accounts for fatty acid.
Further, the milk protein includes whey protein concentrate, milk protein concentrate, milk protein isolate, whey
Protein isolate, it is any one or more than one in desalted whey powder.
Further, the composite mineral matter is that can provide the compound of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium；Described
Composite mineral matter is that every gram of composite mineral matter contains: calcium: 200mg；Iron: 4mg；Zinc: 2.0mg；Magnesium: 18mg.
Further, the multi-vitamins include vitamin A, vitamin D, vitamin E, vitamin C, vitamin
B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid etc. compound；Every gram of multi-vitamins contain: vitamin
A:6000IU；Vitamin D: 2460IU；Vitamin E: 100mg；Vitamin C: 150mg；Vitamin B6: 4270 μ g；Folic acid: 1100
μg。
Said milk powder is prepared using wet process；The step of wet process prepares milk powder include:
(1) raw material are mixed with water, obtains feed liquid A；
(2) feed liquid A is mixed with multi-vitamins, alpha-lipoic acid, composite mineral matter, and through homogeneous, sterilized, spray drying
Obtain material B；
(3) material B is sieved, packaging is got product.
Homogeneous is double-stage homogenization in the wet bench step (2), wherein the pressure of level-one homogeneous is 15MPa, second level
Homogenization pressure is 1.5MPa, and the homogenizing temperature is 55 DEG C.
The temperature sterilized in the wet bench step (2) is 85 DEG C, and sterilizing time is 30 seconds.
The inlet air temperature being spray-dried in the wet bench step (2) is 165 DEG C, and temperature of outgoing air is 80 DEG C.
The Major Nutrient Indexs measure of 1 gained milk powder of embodiment the results are shown in Table 1:
1 main component testing result of table
| Project | Index |
| Protein (g/100g) | 18.5 |
| Fatty (g/100g) | 19.8 |
| Resistant dextrin (g/100g) | 8.9 |
| Alpha-lipoic acid (mg/100g) | 345 |
Embodiment two: a kind of auxiliary hyperglycemic milk powder provided by the invention, raw material include cow's milk 96.53%, resistance paste
Essence 2.30%, medium chain triglyceride 0.91%, the percentage is the mass percent that each component quality accounts for raw material, remaining
Amount is water.
Raw material further include alpha-lipoic acid 0.0230%, composite mineral matter 0.1843% and multi-vitamins 0.0231%,
The percentage is the mass percent that each component quality accounts for raw material.
The medium chain triglyceride is that fatty acid forms octanoic acid 50%-75%, the medium chain triglyceride three of certain herbaceous plants with big flowers acid 25%-45%
Ester, the percentage are the mass percent that each component quality accounts for fatty acid.
The milk protein includes whey protein concentrate, milk protein concentrate, milk protein isolate, whey protein isolate,
It is any one or more than one in desalted whey powder.
The composite mineral matter is that can provide one of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium or multiple compounds；It is described
Composite mineral matter be every gram of composite mineral matter contain: calcium: 450mg；Iron: 10mg；Zinc: 4.5mg；Magnesium: 65mg.
The multi-vitamins include vitamin A, vitamin D, vitamin E, vitamin C, vitamin B1, vitamin B2、
Vitamin B6, vitamin B12, niacin, folic acid, one of pantothenic acid etc. or a variety of；Every gram of multi-vitamins contain: vitamin A:
14500IU；Vitamin D: 2460IU；Vitamin E: 200mg；Vitamin C: 500mg；Vitamin B6: 6500 μ g；Folic acid: 2400 μ
g。
Prepare said milk powder using wet process: the step of wet process prepares milk powder includes:
(1) water is preheated to 45 DEG C, then by the resistant dextrin, medium chain triglyceride, milk protein, inulin,
Water is uniformly mixed, and mixing temperature is 45 DEG C, obtains mixed liquor A；
(2) multi-vitamins, alpha-lipoic acid, composite mineral matter and the mixed liquor A are uniformly mixed, are carried out equal
Matter is sterilized, and spray drying obtains material B；
(3) it is sieved, packs to the material B to obtain the final product.
Middle homogeneous is double-stage homogenization in the wet bench step (2), wherein the pressure of level-one homogeneous is 25MPa,
Double-stage homogenization pressure is 2.5MPa, and the homogenizing temperature is 65 DEG C.
The temperature sterilized in the wet bench step (2) is 90 DEG C, and sterilizing time is 45 seconds.
The inlet air temperature being spray-dried in the wet bench step (2) is 185 DEG C, and temperature of outgoing air is 95 DEG C.
The Major Nutrient Indexs measure of 2 gained milk powder of embodiment the results are shown in Table 2:
2 main component testing result of table
| Project | Index |
| Protein (g/100g) | 25.3 |
| Fatty (g/100g) | 8.5 |
| Resistant dextrin (g/100g) | 18.0 |
| Alpha-lipoic acid (mg/100g) | 210 |
Embodiment three: a kind of auxiliary hyperglycemic milk powder provided by the invention, raw material include milk protein 76.50%, are resisted
Property dextrin 12.90%, inulin 8.10%, surplus is water, and the percentage is that each component quality accounts for the quality percentages of raw material
Than.
Raw material further include alpha-lipoic acid 0.5000%, composite mineral matter 1.6000% and multi-vitamins 0.2%, described
Percentage be that each component quality accounts for the mass percents of raw material.
The milk protein includes whey protein concentrate, milk protein concentrate, milk protein isolate, whey protein isolate,
It is any one or more than one in desalted whey powder.
The composite mineral matter is that can provide the compound of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium；The composite mineral matter
Contain for every gram of composite mineral matter: calcium: 400mg；Iron: 7mg；Zinc: 3mg；Magnesium: 50mg.
The multi-vitamins include vitamin A, vitamin D, vitamin E, vitamin C, vitamin B1, vitamin B2、
Vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid compound；Every gram of multi-vitamins contain: vitamin A: 9000IU；Dimension life
Plain D:2200IU；Vitamin E: 150mg；Vitamin C: 400mg；Vitamin B6: 6000 μ g；Folic acid: 2000 μ g.
It is combined using wet-dry change and prepares the milk powder.The step of preparing milk powder, is combined using wet process and dry method:
(21) resistant dextrin, milk protein, inulin and water are uniformly mixed, mixing temperature is 55 DEG C, obtains mixed liquor A；
(22) homogeneous is carried out to the mixed liquor A, sterilized, material B is made in spray drying；
(23) the material B, multi-vitamins, composite mineral matter and alpha-lipoic acid are uniformly mixed, are sieved, packaging is
?.
Water in the step (21) is deionized water, and temperature is 55 DEG C.
State in step (21) and be first uniformly mixed resistant dextrin with inulin 2:1 in mass ratio, then with other in raw material at
Divide mixing.
Homogeneous is double-stage homogenization in the wet-dry change binding operation step (22), wherein the pressure of level-one homogeneous is
20MPa, double-stage homogenization pressure are 2MPa, and the homogenizing temperature is 50 DEG C.
The temperature sterilized in the wet-dry change binding operation step (22) is 87 DEG C, and sterilizing time is 40 seconds.
The inlet air temperature being spray-dried in the wet-dry change binding operation step (22) is 170 DEG C, temperature of outgoing air 90
℃。
The Major Nutrient Indexs measure of 3 gained milk powder of embodiment the results are shown in Table 3:
3 main component testing result of table
| Project | Index |
| Protein (g/100g) | 26.4 |
| Fatty (g/100g) | 4.5 |
| Resistant dextrin (g/100g) | 13.0 |
| Alpha-lipoic acid (mg/100g) | 508 |
Example IV: a kind of auxiliary hyperglycemic milk powder provided by the invention, raw material include cow's milk 94.45%, resistance paste
Essence 2.64%, medium chain triglyceride 0.52%, milk protein 1.52%, inulin 0.57%, surplus is water, and the percentage is
Each component quality accounts for the mass percent of raw material.
Raw material further include alpha-lipoic acid 0.0148%, composite mineral matter 0.2371% and multi-vitamins 0.0297%,
The percentage is the mass percent that each component quality accounts for raw material.
The cream source is that raw milk and skimmed milk are mixed by any mass ratio；
The medium chain triglyceride is that fatty acid forms octanoic acid 50%-75%, the medium chain triglyceride three of certain herbaceous plants with big flowers acid 25%-45%
Ester, the percentage are the mass percent that each component quality accounts for fatty acid.
The milk protein includes whey protein concentrate, milk protein concentrate, milk protein isolate, whey protein isolate,
Desalted whey powder.
The composite mineral matter is that can provide the compound of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium；The composite mineral matter
Contain for every gram of composite mineral matter: calcium: 250mg；Iron: 5mg；Zinc: 4mg；Magnesium: 35mg.
The multi-vitamins include vitamin A, vitamin D, vitamin E, vitamin C, vitamin B1, vitamin B2、
Vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid compound；Every gram of multi-vitamins contain: vitamin A: 7000IU；Dimension life
Plain D:1500IU；Vitamin E: 190mg；Vitamin C: 350mg；Vitamin B6: 5000 μ g；Folic acid: 1500 μ g.
It is combined using wet-dry change and prepares the milk powder.The step of preparing milk powder, is combined using wet process and dry method:
(21) cow's milk, resistant dextrin, milk protein, medium chain triglyceride, inulin and water are uniformly mixed, mixing temperature is
50 DEG C, obtain mixed liquor A；
(22) homogeneous is carried out to the mixed liquor A, sterilized, material B is made in spray drying；
(23) the material B, multi-vitamins, composite mineral matter and alpha-lipoic acid are uniformly mixed, are sieved, packaging is
?.
Water in the step (21) is deionized water, and temperature is 50 DEG C.
Medium chain triglyceride is first preheated to 50 DEG C in the step (21), then is mixed with ingredients other in raw material.
State in step (21) and be first uniformly mixed resistant dextrin with inulin 2:1 in mass ratio, then with other in raw material at
Divide mixing.
Homogeneous is double-stage homogenization in the wet-dry change binding operation step (22), wherein the pressure of level-one homogeneous is
20MPa, double-stage homogenization pressure are 2MPa, and the homogenizing temperature is 50 DEG C.
The temperature sterilized in the wet-dry change binding operation step (22) is 87 DEG C, and sterilizing time is 40 seconds.
The inlet air temperature being spray-dried in the wet-dry change binding operation step (22) is 180 DEG C, temperature of outgoing air 85
℃。
The Major Nutrient Indexs measure of 4 gained milk powder of embodiment the results are shown in Table 4:
4 main component testing result of table
| Project | Index |
| Protein (g/100g) | 22.6 |
| Fatty (g/100g) | 11.7 |
| Resistant dextrin (g/100g) | 18.0 |
| Alpha-lipoic acid (mg/100g) | 103 |
The Acceleration study of shelf life is carried out to the auxiliary hyperglycemic milk powder of embodiment 1-4.The aluminium foil bag that is packaged as of milk powder fills
Nitrogen packaging, acceleration environment are 40 DEG C, relative humidity 75%, the acceleration time 8 weeks, carry out shelf life in sampling in the 0th, 2,4,6,8 week
Acceleration study.The index of detection mainly includes milk powder in accelerated period brew and grows smell and alpha-lipoic acid content.Milk powder punching
Tonality and taste odor evaluations method are as follows: in the different time points of acceleration, asking 20 respectively is sense organ criticism personnel to above-mentioned sample
Carry out brew and grow smell to be evaluated, evaluation method is blind sample (4 groups of sample random labellings are a, b, c, d).Specific evaluation
Standard is as shown in table 5.
The evaluation criterion of 5 sensory evaluation of table
6 embodiment 1-4 Acceleration study result of table
By the acceleration result of table 6 it is found that the milk powder shelf stable of embodiment 1-4,40 DEG C Acceleration study 8 weeks, in milk powder
Alpha-lipoic acid be constantly in stable state, and in the brew of entire acceleration period and grow smell without significant change, still locate
In grade " good " or more.This illustrates that embodiment 1-4 milk powder has stronger stability.
Wet processing and dry and wet hybrid technique are compared for the mixed of vitamin and alpha-lipoic acid with embodiment 2 and embodiment 3
Close the influence of the uniformity.Compound basis wet processing of the same race produces 3 batches of milk powder, and dry and wet mixing method produces 3 batches of milk powder,
After the completion of each production of milk powder, the detection of vitamin A, vitamin D, vitamin C, vitamin E and alpha-lipoic acid in milk powder, knot are carried out
Fruit is shown in Table 7.
7 various processes milk powder mixture homogeneity of table
By the experimental result of table 7 it is found that 3 each vitamin contents of batch milk powder of wet production and the 3 of wet-dry change production
The content fluctuation of a each vitamin of batch milk powder also less (initial value), illustrates that wet process and wet-dry change production technology can meet cream
The production of powder.Compare different batches vitamin A, vitamin D, vitamin C, vitamin E and the alpha-lipoic acid of the production of two kinds of technique
Relative standard deviation it is found that all Testing index RSD are no more than 10%, these results suggest that the cream of wet process and wet-dry change production
Powder can meet the production requirement of milk powder, and each vitamin is more evenly distributed between the product of wet production its batch.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field
For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair
Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (15)
1. a kind of auxiliary hyperglycemic milk powder, which is characterized in that raw material include cow's milk 0.00%-96.53%, resistant dextrin
1.43%-12.90%, medium chain triglyceride 0.00%-0.91%, inulin 0.00%-8.10%, milk protein 0.00%-
76.50%, the percentage is the mass percent that each component quality accounts for raw material.
2. auxiliary hyperglycemic milk powder according to claim 1, which is characterized in that raw material further include alpha-lipoic acid
0.0148%-0.5000%, composite mineral matter 0.1843-1.6000% and multi-vitamins 0.0213-0.2%, described hundred
Divide the mass percent than accounting for raw material for each component quality.
3. auxiliary hyperglycemic milk powder according to claim 1, which is characterized in that the medium chain triglyceride is fatty acid group
At sad 50%-75%, the medium chain triglyceride of certain herbaceous plants with big flowers acid 25%-45%, the percentage is that each component quality accounts for fatty acid
Mass percent.
4. auxiliary hyperglycemic milk powder according to claim 1, which is characterized in that the milk protein includes condensed whey egg
White, milk protein concentrate, milk protein isolate, whey protein isolate are any one or more than one in desalted whey powder.
5. auxiliary hyperglycemic milk powder according to claim 2, which is characterized in that the composite mineral matter is that can provide
One of calcium, iron, zinc, phosphorus, magnesium, iodine, potassium or multiple compounds；The composite mineral matter is that every gram of composite mineral matter contains:
Calcium: 200-450mg；Iron: 4.0-10mg；Zinc: 2.0-4.5mg；Magnesium: 18-65mg.
6. auxiliary hyperglycemic milk powder according to claim 2, which is characterized in that the multi-vitamins include vitamin
A, vitamin D, vitamin E, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid etc.
One of or it is a variety of；Every gram of multi-vitamins contain: vitamin A: 6000-14500IU；Vitamin D: 1300-2460IU；Dimension life
Plain E:100-200mg；Vitamin C: 150-500mg；Vitamin B6: 4270-6500 μ g；Folic acid: 1100-2400 μ g.
7. the preparation method of auxiliary hyperglycemic milk powder described in a kind of any one of 1-6 claim, which is characterized in that use wet process
And/or dry and wet mixing method prepares the milk powder.
8. preparation method according to claim 7, which is characterized in that the step of wet process prepares milk powder include:
(1) cow's milk or water are preheated to 45-55 DEG C, then by the resistant dextrin, medium chain triglyceride, milk protein,
Inulin, cow's milk and water are uniformly mixed, and mixing temperature is 45-55 DEG C, obtain mixed liquor A；
(2) multi-vitamins, alpha-lipoic acid, composite mineral matter and the mixed liquor A are uniformly mixed, carry out homogeneous, kills
Bacterium, spray drying, obtains material B；
(3) it is sieved, packs to the material B to obtain the final product.
9. auxiliary hyperglycemic method for preparing milk according to claim 7, which is characterized in that mutually tied using wet process with dry method
Conjunction prepares the step of milk powder:
(21) cow's milk, resistant dextrin, milk protein, medium chain triglyceride, inulin and water are uniformly mixed, mixing temperature 45-
55 DEG C, obtain mixed liquor A；
(22) homogeneous is carried out to the mixed liquor A, sterilized, material B is made in spray drying；
(23) the material B, multi-vitamins, composite mineral matter and alpha-lipoic acid are uniformly mixed, are sieved, pack to obtain the final product.
10. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly the water in (2), in the step (21) is deionized water, and temperature is 45-55 DEG C.
11. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly medium chain triglyceride is first preheated to 45-55 DEG C in (2), in the step (21), then is mixed with ingredients other in raw material.
12. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly first resistant dextrin is uniformly mixed with inulin 2:1 in mass ratio in (2), in the step (21), then with other in raw material
Ingredient mixing.
13. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly homogeneous is double-stage homogenization in (2), in the wet-dry change binding operation step (22), wherein the pressure of level-one homogeneous is 15-
25MPa, double-stage homogenization pressure are 1.5-2.5MPa, and the homogenizing temperature is 55-65 DEG C.
14. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly the temperature sterilized in (2), in the wet-dry change binding operation step (22) is 85-90 DEG C, and sterilizing time is 30-45 seconds.
15. auxiliary hyperglycemic method for preparing milk according to claim 8 or claim 9, which is characterized in that the wet bench step
Suddenly the inlet air temperature being spray-dried in (2), in the wet-dry change binding operation step (22) is 165-185 DEG C, temperature of outgoing air
It is 80-95 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811611351.0A CN109699744A (en) | 2018-12-27 | 2018-12-27 | A kind of auxiliary hyperglycemic milk powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811611351.0A CN109699744A (en) | 2018-12-27 | 2018-12-27 | A kind of auxiliary hyperglycemic milk powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109699744A true CN109699744A (en) | 2019-05-03 |
Family
ID=66258661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811611351.0A Pending CN109699744A (en) | 2018-12-27 | 2018-12-27 | A kind of auxiliary hyperglycemic milk powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109699744A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111685184A (en) * | 2020-07-02 | 2020-09-22 | 生庆海 | Food with auxiliary blood sugar reducing function |
| CN112042753A (en) * | 2020-09-16 | 2020-12-08 | 甘肃华羚乳品股份有限公司 | Modified milk powder suitable for diabetes patients and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5569670A (en) * | 1992-06-05 | 1996-10-29 | Asta Medica Aktiengesellschaft | Combination medications containing alpha-lipoic acid and related |
| CN101703109A (en) * | 2009-10-27 | 2010-05-12 | 吕学栋 | Composite milk protein with functions of regulating blood lipid and reducing blood sugar |
| CN102090453A (en) * | 2011-02-21 | 2011-06-15 | 苟春虎 | Weight-reducing and beautifying milk tea |
| CN104489102A (en) * | 2014-12-26 | 2015-04-08 | 光明乳业股份有限公司 | Milk powder for middle and old age people and preparation method thereof |
| CN106720370A (en) * | 2016-11-17 | 2017-05-31 | 光明乳业股份有限公司 | A kind of person in middle and old age's milk powder containing oryzanol and preparation method thereof |
-
2018
- 2018-12-27 CN CN201811611351.0A patent/CN109699744A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5569670A (en) * | 1992-06-05 | 1996-10-29 | Asta Medica Aktiengesellschaft | Combination medications containing alpha-lipoic acid and related |
| CN101703109A (en) * | 2009-10-27 | 2010-05-12 | 吕学栋 | Composite milk protein with functions of regulating blood lipid and reducing blood sugar |
| CN102090453A (en) * | 2011-02-21 | 2011-06-15 | 苟春虎 | Weight-reducing and beautifying milk tea |
| CN104489102A (en) * | 2014-12-26 | 2015-04-08 | 光明乳业股份有限公司 | Milk powder for middle and old age people and preparation method thereof |
| CN106720370A (en) * | 2016-11-17 | 2017-05-31 | 光明乳业股份有限公司 | A kind of person in middle and old age's milk powder containing oryzanol and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111685184A (en) * | 2020-07-02 | 2020-09-22 | 生庆海 | Food with auxiliary blood sugar reducing function |
| CN112042753A (en) * | 2020-09-16 | 2020-12-08 | 甘肃华羚乳品股份有限公司 | Modified milk powder suitable for diabetes patients and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007236638B2 (en) | Fat accumulation inhibitor | |
| US20190335796A1 (en) | Optimized nutrient food | |
| JP2599400B2 (en) | Formulated liquid nutritional composition for glucose intolerant patients | |
| CN105613789A (en) | High-fat and high-dietary-fiber composite animal and plant powdered oil and preparation method and application thereof | |
| JP4231208B2 (en) | Nutritional supplements derived from fermented milk for the prevention of osteoporosis | |
| CN101548698A (en) | Humanized milk and preparation method thereof | |
| CN105876585A (en) | Protein solid beverage and preparation method and application thereof | |
| CN101595977A (en) | Be of value to the formula food and the application thereof of eyes duration of photopic vision | |
| CN101415429B (en) | Fat accumulation inhibitor | |
| WO2016121923A1 (en) | Muscle synthesis promoter | |
| CN107279296A (en) | A kind of formula food of suitable diabetes and preparation method thereof | |
| CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
| CN109699744A (en) | A kind of auxiliary hyperglycemic milk powder and preparation method thereof | |
| CN101496607B (en) | Barley seedling and buckwheat seedling composite fresh-keeping beverage and preparation method thereof | |
| CN106720370A (en) | A kind of person in middle and old age's milk powder containing oryzanol and preparation method thereof | |
| CN103859039A (en) | Liquid milk composition beneficial for improving children immunity | |
| JP2011500016A (en) | Infant infant formula containing green tea and lactic acid bacteria | |
| JP2017057147A (en) | Composition comprising garlic and the like, low-salinity miso, and vitamin b1 | |
| JP4673071B2 (en) | Iron-adsorptive polymer substance, iron-containing polymer substance, and production method thereof | |
| CN102342396B (en) | Oral liquid containing xylitol zinc calcium | |
| CN108142743A (en) | A kind of functional form composite beverage containing corn stigma and preparation method thereof | |
| JP4578590B2 (en) | Nutritional composition | |
| KR100584888B1 (en) | A beverage with herb remedy and eel, and manufacturing method thereof | |
| AU2010309857A1 (en) | Use of extracts from Salonum glaucophyllum for treating bone metabolism disorders and kidney disorders | |
| CN110934828A (en) | Asarone oral emulsion and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190503 |